The Role of Radiation Therapy in the Management of Thyroid Cancer

Surgical Oncology Clinics of North America

Volumn 17, Issue 1, 2008, Pages 219-232

  Strasser, Jon F ^a   Raben, Adam ^a   Koprowski, Chris ^a  

^a HELEN F GRAHAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ANAPLASTIC CARCINOMA; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; FOLLICULAR CARCINOMA; FOLLOW UP; HISTOPATHOLOGY; HUMAN; ONCOCYTOMA; REVIEW; STATISTICAL SIGNIFICANCE; THYROID CANCER; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TREATMENT PLANNING;

CARCINOMA; CARCINOMA, MEDULLARY; HUMANS; RADIOTHERAPY; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 37449012330     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2007.10.005     Document Type: Review

References (46)

1. Goldman N.D., Coniglio J.U., and Falk S.A. Thyroid cancers. I. Papillary, follicular, and Hürthle cell. Otolaryngol Clin North Am 29 4 (1996) 593-609
2. Sheline G.E. Radiation therapy in the control of persistent thyroid cancer. Am J Roentgenol Radium Ther Nucl Med 97 4 (1966) 923-930
3. O'Connell M.E. Results of external beam radiotherapy in differentiated thyroid carcinoma: a retrospective study from the Royal Marsden Hospital. Eur J Cancer 30A 6 (1994) 733-739
4. Simpson W.J., Panzarella T., Carruthers J.S., et al. Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys 14 6 (1988) 1063-1075
5. Simpson W.J., McKinney S.E., Carruthers J.S., et al. Papillary and follicular thyroid cancer: prognostic factors in 1578 patients. Am J Med 83 3 (1987) 479-488
6. Tubiana M., Haddad E., Schlumberger M., et al. External radiotherapy in thyroid cancers. Cancer 55 (1985) 2062-2071
7. Mazzaferri E.L., and Young R.L. Papillary thyroid carcinoma: a 10-year follow-up report of the impact of therapy in 576 patients. Am J Med 70 (1981) 511-517
8. Benker G., Olbricht T., Reinwein D., et al. Survival rates in patients with differentiated thyroid carcinoma: influence of postoperative external radiotherapy. Cancer 65 (1990) 1517-1520
9. Farahati J., Reinders C., Stuschke M., et al. Differentiated thyroid cancer: impact of adjuvant external radiotherapy with perithyroidal tumor infiltration (stage pT4). Cancer 77 1 (1996) 172-180
10. Tsang R.W., Brierly J.D., Simpson W.J., et al. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 82 2 (1998) 375-388
11. Chow S.M., Law S.C., Mendenhall W.M., et al. Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy. Int J Radiat Oncol Biol Phys 52 (2002) 784-795
12. Passler C., Scheuba C., Prager G., et al. Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocr Relat Cancer 11 1 (2004) 131-139
13. Furlan J.C., Bedard Y.C., and Rosen I.B. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas. J Am Coll Surg 198 3 (2004) 341-348
14. Furlan J.C., Bedard Y.C., and Rosen I.B. Significance of tumor capsular invasion in well-differentiated thyroid carcinomas. Am Surg 73 5 (2007) 484-491
15. Shaha A.R. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope 114 (2004) 393-402
16. Saad M., Ordonez N., Rashid R., et al. Medullary carcinoma of the thyroid: a study of the clinical features and prognostic factors in 161 patients. Medicine 63 (1984) 319-342
17. Deftos L.J., and Stein M.F. Radioiodine as an adjunct to the surgical treatment of medullary thyroid carcinoma. J Clin Endocrinol Metab 50 (1980) 967-968
18. Hellman D.E., Kartchner M., Van Antwerp J.D., et al. Radioiodine in the treatment of medullary carcinoma of the thyroid. J Clin Endocrinol Metab 48 (1979) 451-455
19. Halnan K.E. The non-surgical treatment of thyroid cancer. Br J Surg 62 (1975) 769-771
20. Steindfeld A.D. The role of radiation therapy in medullary carcinoma of the thyroid. Radiology 123 (1977) 745-746
21. Simpson W.J., Palmer J.A., Rosen I.B., et al. Management of medullary carcinoma of the thyroid. Am J Surg 144 (1982) 420-422
22. Samaan N.A., Schultz P.N., and Hickey R.C. Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy. J Clin Endocrinol Metab 67 (1988) 801-805
23. Fife K.M., Bower M., and Harmer C.L. Medullary thyroid cancer: the role of radiotherapy in local control. Eur J Surg Oncol 22 (1996) 588-591
24. Rougier P., Parmentier C., Laplanche A., et al. Medullary thyroid carcinoma: prognostic factors and treatment. Int J Radiat Oncol Biol Phys 9 (1983) 161-169
25. Nguyen T.D., Chassard J.L., Lagarde P., et al. Results of postoperative radiation therapy in medullary carcinoma of the thyroid: a retrospective study by the French Federation of Cancer Institutes-the Radiotherapy Cooperative Group. Radiother Oncol 23 (1992) 1-5
26. Brierley J., Tsang R., Simpson W.J., et al. Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control. Thyroid 6 (1996) 305-310
27. Heron D.E., Karimpour S., and Grigsby W. Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups. Am J Clin Oncol 25 (2002) 442-446
28. Levendag P.C., De Porre P.M., and van Putten W.L. Anaplastic carcinoma of the thyroid gland treated by radiation therapy. Int J Radiat Oncol Biol Phys 26 (1993) 125-128
29. Venkatesh Y.S., Ordonez N.G., Schultz P.N., et al. Anaplastic carcinoma of the thyroid: a clinicopathologic study of 121 cases. Cancer 66 (1990) 321-330
30. Nel C.J., van Heerden J.A., Goellner J.R., et al. Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases. Mayo Clin Proc 60 (1985) 51-58
31. Kobayashi T., Asakawa H., Umeshita K., et al. Treatment of 37 patients with anaplastic carcinoma of the thyroid. Head Neck 18 (1996) 36-41
32. Demeter J.G., De Jong S.A., Lawrence A.M., et al. Anaplastic thyroid carcinoma: risk factors and outcome. Surgery 110 (1991) 956-961
33. Junor E.J., Paul J., and Reed N.S. Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. Eur J Surg Oncol 18 (1992) 83-88
34. Voutilainen P.E., Multanen M., Haapiainen R.K., et al. Anaplastic thyroid carcinoma survival. World J Surg 23 (1999) 975-978
35. Brignardello E., Gallo M., Baldi I., et al. Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single institution in the past 5 years. Eur J Endocrinol 156 (2007) 425-430
36. Kebebew E., Greenspan F.S., Clark O., et al. Anaplastic thyroid carcinoma: treatment outcome and prognostic factors. Cancer 103 (2005) 1330-1335
37. Heron D.E., Karimpour S., and Grigsby P.W. Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation in two groups. Am J Clin Oncol 25 (2002) 442-446
38. Tennvall J., Lundell G., Wahlberg P., et al. Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy, and surgery. Br J Cancer 86 (2002) 1848-1853
39. Kim J.H., and Leeper R.D. Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy. Cancer 60 (1987) 2372-2375
40. Lang B.H., and Lo C.Y. Surgical options in undifferentiated thyroid carcinoma. World J Surg 31 (2007) 969-977
41. Eisbruch A., Ten Haken R.K., Kim H.M., et al. Dose, volume and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45 (1999) 577-587
42. Brizel D.M., Wesserman T.H., Henke M., et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18 (2000) 3339-3345
43. Wasserman T.H., Brizel D.M., Henke M., et al. Influence of intravenous amifostine on xerostomic tumor control, and survival after radiotherapy for head-and-neck cancer: 2-year follow up of prospective, randomized phase III trial. Int J Radiat Oncol Biol Phys 63 (2005) 985-990
44. Bardet E, Martin L, Calais G, et al. Subcutaneous (SbQ) versus intravenous (IV) administration of amifostine for head and neck (HN) cancer patients receiving radiotherapy (RT): preliminary results of the GORTEC 2000-02 randomized trial [abstract 211]. Presented at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology. Denver (CO), October 16-20, 2005.
45. Boccia R., Anne P.R., Bourhis J., et al. Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP). Int J Radiat Oncol Biol Phys 60 (2004) 302-309
46. Spielberger R., Stiff P., Bensinger W., et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351 (2004) 2590-2598